Style | Citing Format |
---|---|
MLA | Naghshineh E, Khani B, Mesgari L. "The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome." Journal of Isfahan Medical School, vol. 38, no. 606, 2021, pp. 982-988. |
APA | Naghshineh E, Khani B, Mesgari L (2021). The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome. Journal of Isfahan Medical School, 38(606), 982-988. |
Chicago | Naghshineh E, Khani B, Mesgari L. "The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome." Journal of Isfahan Medical School 38, no. 606 (2021): 982-988. |
Harvard | Naghshineh E, Khani B, Mesgari L (2021) 'The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome', Journal of Isfahan Medical School, 38(606), pp. 982-988. |
Vancouver | Naghshineh E, Khani B, Mesgari L. The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome. Journal of Isfahan Medical School. 2021;38(606):982-988. |
BibTex | @article{ author = {Naghshineh E and Khani B and Mesgari L}, title = {The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome}, journal = {Journal of Isfahan Medical School}, volume = {38}, number = {606}, pages = {982-988}, year = {2021} } |
RIS | TY - JOUR AU - Naghshineh E AU - Khani B AU - Mesgari L TI - The Efficiency of Gnrh Antagonist (Cetrotide) in Comparison of Cabergoline in the Prevention and Treatment of Ovarian Hyperstimulation Syndrome JO - Journal of Isfahan Medical School VL - 38 IS - 606 SP - 982 EP - 988 PY - 2021 ER - |